The special challenge of nonadherence with sublingual immunotherapy

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 2, 2014, Pages 152-155

  Bender, Bruce G ^a   Oppenheimer, John ^b  

^a DEPARTMENT OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Adherence; Sublingual immunotherapy

Indexed keywords

COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; EDUCATION PROGRAM; FOLLOW UP; HUMAN; INFORMATION TECHNOLOGY; PATIENT ADVOCACY; PATIENT COMPLIANCE; PATIENT INFORMATION; REVIEW; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW; TELECOMMUNICATION; TREATMENT REFUSAL;

ADHERENCE; SUBLINGUAL IMMUNOTHERAPY;

FOLLOW-UP STUDIES; HUMANS; PATIENT COMPLIANCE; SUBLINGUAL IMMUNOTHERAPY; TELECOMMUNICATIONS;

EID: 84895475547     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.01.003     Document Type: Review

References (43)

1. Eaton D.K., Kann L., Kinchen S., Shanklin S., Flint K.H., Hawkins J., et al. Youth risk behavior surveillance-United States, 2011. MMWR Surveill Summ 2012, 61:1-162.
2. Wiegand P., McCombs J., Wang J. Factors of hyperlipidemia medication adherence in a nationwide health plan. Am J Manag Care 2012, 18:193-199.
3. Shaw R., Bosworth H. Baseline medication adherence and blood pressure in a 24-month longitudinal hypertension study. JClin Nurs 2012, 21:1401-1406.
4. Egede L., Gebregziabher M., Dismuke C., Lynch C.P., Axon R.N., Zhao Y., et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care 2012, 35:2533-2539.
5. Vestbo J., Anderson J., Calverley P., Celli B., Ferguson G.T., Jenkins C., et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009, 64:939-943.
6. Williams L., Peterson E., Wells K., Ahmedani B.K., Kumar R., Burchard E.G., et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. JAllergy Clin Immunol 2011, 128:1185-1191.
7. Krishnan J., Bender B., Wamboldt F., Szefler S.J., Adkinson N.F., Zeiger R.S., et al. Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. JAllergy Clin Immunol 2011, 129:112-118.
8. Bender B., Pedan A., Varasteh L. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. JAllergy Clin Immunol 2006, 118:899-904.
9. Huetsch J., Uman J., Udris E., Au D. Predictors of adherence to inhaled medications among veterans with COPD. JGen Intern Med 2012, 27:1506-1512.
10. Evans C., Eurich D., Remillard A., Shevchuk Y., Blackburn D. First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study. Am J Hypertens 2012, 25:195-203.
11. Penning-van B., Van Herk-Sukel M., Gale R., Lammers J., Herings R. Three-year dispensing patterns with long-acting inhaled drugs, in COPD: a database analysis. Respir Med 2011, 105:259-265.
12. Osterberg L., Blaschke T. Adherence to medication. NEng J Med 2005, 353:487-497.
13. Bosworth H., Granter B., Mendy P., Brindis R., Burkholder R., Czajkowski S.M., et al. Medication adherence: a call for action. Am Heart J 2011, 162:412-424.
14. National Council on Patient Information and Education. Enhancing prescription medication adherence: a national action plan. 2007. Available from: Accessed December 8, 2013. http://www.talkabouttrx.org/documents/enhancing.prescription_medicine_adherence.pdf.
15. Claes C., Mittendorf T., GravvonderSchulenburg J. Persistence and frequency of prescriptions of subcutaneous allergen-specific immunotherapy (SCIT) prescribed with the German statutory health insurance. Med Klin (Munich) 2009, 104:536-542.
16. Kiel M., Roder E., Gerth van Wijk R., Al M., Hop W., Rutten-van Molken M. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. JAllergy Clin Immunol 2013, 132:353-360.
17. Hsu N., Reisacher W. Acomparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy. Int Forum Allergy Rhinol 2012, 2:280-284.
18. Stokes S., Quinn J., Sacha J., White K. Adherence to imported fire ant subcutaneous immunotherapy. Ann Allergy Asthma Immunol 2013, 110:165-167.
19. Stempel D., Stoloff S., Carranza Rosenzweig J., Stanford R., Ryskina K., Legorreta A. Adherence to asthma controller medication regimens. Respir Med 2005, 99:1263-1267.
20. Ducharme F., Noya F., Allen-Ramey F., Maiese E., Gingras J., Blais L. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors. Curr Med Res Opin 2012, 28:111-119.
21. Marogna M., Spadolini I., Massolo A., Canonica G., Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. JAllergy Clin Immunol 2010, 126:969-975.
22. Skoner D., Gentile D., Bush R., Fasano M., McLaughlin A., Esch R. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen. JAllergy Clin Immunol 2010, 125:660-666. 666.e1-e4.
23. Amar S., Harbeck R., Sills M., Silveira L., O'Brien H., Nelson H. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. JAllergy Clin Immunol 2009, 124:150-156.
24. Savi E., Peveri S., Senna G., Passalacqua G. Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach. Allergy 2013, 68:1193-1195.
25. Schillinger D., Piette J., Grumbach K., Wang F., Wilson C., Daher C., et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 2003, 163:83-90.
26. Wensing M., Elwyn G., Edwards A., Vingerhoets E., Grol R. Deconstructing patient centered communication and uncovering shared decision making: an observational study. BMC Med Inform Decis Mak 2002, 2:2.
27. Wilson S., Strub P., Buist A., Knowles S.B., Lavori P.W., Lapidus J., et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Better Outcomes of Asthma Treatment (BOAT) Study Group. Am J Respir Crit Care Med 2010, 181:566-577.
28. Chan D., Callahan C., Hatch-Pigott V., Lawless A., Proffitt H.L., Manning N.E., et al. Internet-based home monitoring and education of children with asthma is comparable to ideal office-based care: results of a one-year asthma in-home monitoring trial. Am J Health Syst Pharm 2007, 64:497-505.
29. Clark P., Karagoz T., Apikoglu-Rabus S., Izzettin F. Effect of pharmacist-led patient education on adherence to tuberculosis treatment. Am J Health Syst Pharm 2007, 64:497-505.
30. Smith D., Kramer J., Perrin N., Platt R., Roblin D.W., Lane K., et al. Arandomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med 2008, 168:477-483.
31. Bosworth H., Olsen M., Neasry A., Orr M., Grubber J., Svetkey L., et al. Take control of your blood pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns 2008, 70:338-347.
32. Ziller V., Kyvernitakis I., Knoll D., Storch A., Hars O., Hadji P. Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment: the COMPAS study. BMC Cancer 2013, 4(13):407.
33. Macharia W., Leon G., Rowe B. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA 1999, 267:374-378.
34. Glasgow R., Dickinson P., Fisher L., Christiansen S., Toobert D.J., Bender B.G., et al. Use of RE-AIM to develop a multi-media facilitation tool for the patient-centered medical home. Science 2011, 6:118-128.
35. Hughes L., Done J., Young A. Not 2 old 2 TXT: there is potential to use email and SMS text message healthcare reminders for rheumatology patients up to 65 years old. Health Informatics J 2011, 17:266-276.
36. Sternfield B. Improving diet and fitness with ALIVE. A worksite randomized trial. Am J Prev Med 2009, 36:475-483.
37. Montes J., Gomez-Beneyto M., Maurino J. Ashort message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Res 2012, 200:89-95.
38. Stacy J., Schwartz S., Ershoff D., Shreve M. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag 2009, 12:241-254.
39. DeMolles D., Sparrow D., Gottlieb D., Friedman R. Apilot trial of a telecommunications system in sleep apnea management. Med Care 2004, 42:764-769.
40. Vollmer V., Krishner M., Peters D., Drane A., Stilbolt T., Hickey T., et al. Use and impact of an automated telephone outreach system for asthma in a managed care setting. Am J Manag Care 2006, 12:725-733.
41. Vollmer W., Feldstein A., Smith D., Dubanoski J.P., Waterbury A., Schneider J.L., et al. Use of health information to improve medication adherence. Am J Manag Care 2011, 17:SP79-SP87.
42. Vervloet M., Linn A., van Weert J., de Bakker D., Bouvy M., Van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. JAm Med Inform Assoc 2012, 19:696-704.
43. Bender B. Can health care organizations improve health behavior and treatment adherence. Popul Health Manag 2013 Oct 23, [Epub ahead of print.].